Cardiovascular safety of mirabegron: analysis of an integrated clinical trial database of patients with overactive bladder syndrome

2018 ◽  
Vol 12 (11) ◽  
pp. 768-778.e1 ◽  
Author(s):  
William B. White ◽  
Emad Siddiqui ◽  
Tri Tat ◽  
Billy Franks ◽  
Carol R. Schermer
Keyword(s):  
Clinical Trial ◽  
Overactive Bladder ◽  
Overactive Bladder Syndrome ◽  
Cardiovascular Safety ◽  
Clinical Trial Database

scholarly journals Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

2020 ◽  
Vol 77 (1) ◽  
pp. 119-128 ◽  
Author(s):  
Christopher R. Chapple ◽  
Francisco Cruz ◽  
Linda Cardozo ◽  
David Staskin ◽  
Sender Herschorn ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Overactive Bladder ◽  
Safety And Efficacy ◽  
Clinical Trial Database

scholarly journals Cardiovascular Safety of β3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome

2016 ◽  
Vol 69 (2) ◽  
pp. 311-323 ◽  
Author(s):  
Gian Marco Rosa ◽  
Simone Ferrero ◽  
Victor W. Nitti ◽  
Adrian Wagg ◽  
Tahir Saleem ◽  
...  
Keyword(s):  
Overactive Bladder ◽  
Overactive Bladder Syndrome ◽  
Cardiovascular Safety ◽  
Adrenoceptor Agonists
Sign in / Sign up

Export Citation Format

Share Document